MGC Pharmaceuticals Ltd
ASX:MXC
MGC Pharmaceuticals Ltd
ASX:MXC
Price:
0.415
AUD
Market Cap:
AU$18.2m
Balance Sheet
Balance Sheet Decomposition
MGC Pharmaceuticals Ltd
MGC Pharmaceuticals Ltd
Balance Sheet Decomposition is not available for
MGC Pharmaceuticals Ltd
MGC Pharmaceuticals Ltd
Balance Sheet
MGC Pharmaceuticals Ltd
MGC Pharmaceuticals Ltd
Currency: AUD
| Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
0
|
8
|
11
|
10
|
2
|
2
|
5
|
2
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
2
|
0
|
|
| Cash Equivalents |
1
|
0
|
8
|
11
|
10
|
2
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
2
|
1
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Total Current Assets |
1
|
1
|
9
|
12
|
12
|
4
|
3
|
9
|
6
|
3
|
|
| PP&E Net |
4
|
2
|
0
|
1
|
1
|
1
|
4
|
7
|
9
|
7
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
7
|
9
|
7
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
|
| Intangible Assets |
0
|
0
|
7
|
7
|
7
|
5
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
3
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
3
|
1
|
1
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
3
|
0
|
|
| Total Assets |
5
N/A
|
3
-49%
|
16
+549%
|
21
+27%
|
20
-4%
|
13
-35%
|
8
-39%
|
24
+206%
|
19
-23%
|
10
-46%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
3
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
3
|
4
|
6
|
1
|
0
|
4
|
4
|
10
|
|
| Total Current Liabilities |
0
|
0
|
5
|
5
|
7
|
2
|
3
|
6
|
8
|
13
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
4
|
|
| Total Liabilities |
0
N/A
|
1
+38%
|
5
+666%
|
5
+1%
|
6
+32%
|
2
-66%
|
5
+137%
|
10
+116%
|
13
+22%
|
17
+37%
|
|
| Equity | |||||||||||
| Common Stock |
16
|
17
|
32
|
43
|
48
|
49
|
60
|
85
|
97
|
104
|
|
| Retained Earnings |
11
|
15
|
21
|
26
|
35
|
38
|
57
|
71
|
91
|
111
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
5
N/A
|
2
-58%
|
12
+513%
|
16
+37%
|
14
-14%
|
11
-21%
|
3
-72%
|
14
+346%
|
6
-58%
|
7
N/A
|
|
| Total Liabilities & Equity |
5
N/A
|
3
-49%
|
16
+549%
|
21
+27%
|
20
-4%
|
13
-35%
|
8
-39%
|
24
+206%
|
19
-23%
|
10
-46%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
258
|
372
|
919
|
1 097
|
1 203
|
1 213
|
1 576
|
2
|
3
|
3
|
|
Switch to:
Switch to:
See Also
Discover More
